DERBY — Joseph Guarnaccia, M.D., clinical director of the Multiple Sclerosis Treatment Center at Griffin Hospital, was recently inducted [...]
“Both active vaccination/treatment with major capsid protein VP1 of JC polyoma virus and passive vaccination/treatment with broadly [...]
A Phase III trial of MedDay's multiple sclerosis drug has missed its primary endpoint. The drug, which made headlines in April when it [...]
Scientists say they’ve pinpointed the brain cell deaths that seem to trigger MS, and their research could lead to a new treatment. It [...]
Studies show that ocrelizumab works for both the relapsing and progressive forms of MS. Symptoms come and go in most cases of multiple [...]
Multiple sclerosis (MS) patients with histories of neuro-ophthalmic symptoms performed poorly on neuropsychological tasks, according to a [...]
Sleep disorders and epileptic seizures are of higher prevalence in those with multiple sclerosis. Multiple sclerosis is a chronic disease [...]
As a chronic neurological condition, it should come as no surprise that multiple sclerosis can produce psychiatric problems. In fact, [...]
MedicalResearch.com Interview with: Dr. Vittorio Gallo PhD Center for Neuroscience Research Children’s Research [...]
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surprising new view [...]